SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology TRAF6 products
includes other brands or spellings
|
| ic, ip | | Santa Cruz Biotechnology anti-TRAF6 was used in immunoprecipitation to isolate TRAF6 from human HEK cells and in immunocytochemistry to detect the localization of TRAF6 in HEK cells. |
| ip, wb | | Santa Cruz Biotechnology polyclonal anti-TRAF6 antibody was used in western blot and immunoprecipitation to study the role of the soluble envelope glycoprotein gp120 of HIV-1 in RANKL induction and the ability of pharmacologically relevant concentrations of certain PIs to suppress interaction between IFN-gamma and RANKL. |
| ip, wb | | Santa Cruz Biotechnology anti-TRAF6 antibody was used in western blot and immunoprecipitation to study IRF-8 binding to TRAF6 in 293T cells co-transfected with IRF-8 and TRAF6 plasmids for 48 h. |
| ip, wb | | Santa Cruz Biotechnologies anti-TRAF6 antibody was used in western blot and immunoprecipitation to study the effects of p62 scaffold on TRAF6 polyubiquitination and NGF-induced NF-kappaB activation. |
| wb | | Santa Cruz Biotechnology anti-TRAF6 (H-274) was used in western blot to study the cellular and molecular function of a novel interferon- and LPS-inducible gene designated FLN29 that acts as a negative regulator in TLR signaling. |
| wb | | Santa Cruz Biotechnology polyclonal rabbit anti-TRAF6 antibody was used in western blot to detect TRAF3 in CD40 immunoprecipitates from human microvascular endothelial cell lysates. |
| wb | | Santa Cruz Biotechnologies anti-TRAF6 antibody was used in western blot to study the activity of SIGIRR to inhibit interleukin-1 receptor- and Toll-like receptor 4-mediated signaling through different mechanisms. |
| wb | | SCBT anti-TRAF-6 antibody was used in western blot to characterize the effect of pellino3 on MAPK and CREB. |
Articles Reviewed |
| 1. Maria Chiara Deregibus et al. CD40-dependent activation of phosphatidylinositol 3-kinase/Akt pathway mediates endothelial cell survival and in vitro angiogenesis. 2003 |
| 2. J Mohamad Fakruddin et al. HIV envelope gp120-mediated regulation of osteoclastogenesis via receptor activator of nuclear factor kappa B ligand (RANKL) secretion and its modulation by certain HIV protease inhibitors through interferon-gamma/RANKL cross-talk. 2003 |
| 3. M Lamar Seibenhener et al. Sequestosome 1/p62 is a polyubiquitin chain binding protein involved in ubiquitin proteasome degradation. 2004 |
| 4. Jinzhong Qin et al. SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms. 2005 |
| 5. Marion P Butler et al. Pellino3 is a novel upstream regulator of p38 MAPK and activates CREB in a p38-dependent manner. 2005 |
| 6. Marie W Wooten et al. The p62 scaffold regulates nerve growth factor-induced NF-kappaB activation by influencing TRAF6 polyubiquitination. 2005 |
| 7. Ryuichi Mashima et al. FLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signaling. 2005 |
| 8. Jie Zhao et al. IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. 2006 |